2026 Global: Autonomous Surgical Robotics Market-Competitive Review (2032) report
Description
The 2026 Global: Autonomous Surgical Robotics Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for autonomous surgical robotics market by geography and historical trend. The scope of the report extends to sizing of the autonomous surgical robotics market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Intuitive Surgical, Medtronic, Stryker, Johnson & Johnson, CMR Surgical, Zimmer Biomet, Smith+Nephew, Asensus Surgical, Vicarious Surgical, and Moon Surgical are among the ten major companies shaping the autonomous surgical robotics market today. Intuitive Surgical remains the market leader with its da Vinci family, a dominant soft‑tissue platform boasting a multi‑generation installed base and recently introduced next‑generation systems that emphasize force sensing, improved computing and procedural automation features. Medtronic competes across soft‑tissue and spine with Hugo™ RAS and the Mazor portfolio, pursuing broader regulatory approvals and integrating digital surgery capabilities—training, analytics, and cloud workflows—to move toward higher autonomy and intraoperative decision support. Stryker focuses on orthopedics with the Mako SmartRobotics line and successive platform updates that add planning, intraoperative adaptability and tighter imaging–robot integration to reduce variability in joint replacement procedures. Johnson & Johnson (through Auris/Verb Surgical and the OTTAVA program) is building a comprehensive ecosystem that blends advanced imaging, machine learning and modular robotics to enable semi‑automated steps and data‑driven guidance across procedures.
CMR Surgical’s Versius emphasizes modularity, portability and scalability for general surgery, with form‑factor innovations and workflow tools designed to bring robotic capabilities to smaller operating rooms and ambulatory settings as autonomy is introduced incrementally. Zimmer Biomet’s ROSA line targets neurosurgery and orthopedics with strong digital ecosystems (ZBEdge) that support preoperative planning, intraoperative navigation and automation of repetitive tasks to improve reproducibility and speed. Smith+Nephew is advancing compact, outpatient‑focused robotics such as CORI and Coriograph planning tools, coupling image‑agnostic registration and AI‑driven modeling to streamline arthroplasty steps that could be progressively automated. Asensus Surgical (Senhance) differentiates with haptics, augmented intelligence and laparoscopic automation features that aim to augment surgeon control while enabling standardized, semiautonomous maneuvers and performance analytics.
Vicarious Surgical and Moon Surgical represent companies pushing toward deeper automation and novel form factors: Vicarious combines robotics with advanced imaging and telepresence concepts to enable minimally invasive procedures with increased robot autonomy, while Moon Surgical’s Maestro emphasizes modular arms, computer vision and haptic augmentation for task automation and shared control workflows. Across these ten firms, common strategies include specialty focus (soft tissue vs orthopedics vs neuro), modular hardware to lower adoption barriers, integrated digital ecosystems for data collection and AI, and incremental automation of discrete procedural steps rather than full autonomy at once—an approach reflected in regulatory pathways, clinical trials and commercial rollouts documented throughout 2024–2025.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for autonomous surgical robotics market by geography and historical trend. The scope of the report extends to sizing of the autonomous surgical robotics market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Intuitive Surgical, Medtronic, Stryker, Johnson & Johnson, CMR Surgical, Zimmer Biomet, Smith+Nephew, Asensus Surgical, Vicarious Surgical, and Moon Surgical are among the ten major companies shaping the autonomous surgical robotics market today. Intuitive Surgical remains the market leader with its da Vinci family, a dominant soft‑tissue platform boasting a multi‑generation installed base and recently introduced next‑generation systems that emphasize force sensing, improved computing and procedural automation features. Medtronic competes across soft‑tissue and spine with Hugo™ RAS and the Mazor portfolio, pursuing broader regulatory approvals and integrating digital surgery capabilities—training, analytics, and cloud workflows—to move toward higher autonomy and intraoperative decision support. Stryker focuses on orthopedics with the Mako SmartRobotics line and successive platform updates that add planning, intraoperative adaptability and tighter imaging–robot integration to reduce variability in joint replacement procedures. Johnson & Johnson (through Auris/Verb Surgical and the OTTAVA program) is building a comprehensive ecosystem that blends advanced imaging, machine learning and modular robotics to enable semi‑automated steps and data‑driven guidance across procedures.
CMR Surgical’s Versius emphasizes modularity, portability and scalability for general surgery, with form‑factor innovations and workflow tools designed to bring robotic capabilities to smaller operating rooms and ambulatory settings as autonomy is introduced incrementally. Zimmer Biomet’s ROSA line targets neurosurgery and orthopedics with strong digital ecosystems (ZBEdge) that support preoperative planning, intraoperative navigation and automation of repetitive tasks to improve reproducibility and speed. Smith+Nephew is advancing compact, outpatient‑focused robotics such as CORI and Coriograph planning tools, coupling image‑agnostic registration and AI‑driven modeling to streamline arthroplasty steps that could be progressively automated. Asensus Surgical (Senhance) differentiates with haptics, augmented intelligence and laparoscopic automation features that aim to augment surgeon control while enabling standardized, semiautonomous maneuvers and performance analytics.
Vicarious Surgical and Moon Surgical represent companies pushing toward deeper automation and novel form factors: Vicarious combines robotics with advanced imaging and telepresence concepts to enable minimally invasive procedures with increased robot autonomy, while Moon Surgical’s Maestro emphasizes modular arms, computer vision and haptic augmentation for task automation and shared control workflows. Across these ten firms, common strategies include specialty focus (soft tissue vs orthopedics vs neuro), modular hardware to lower adoption barriers, integrated digital ecosystems for data collection and AI, and incremental automation of discrete procedural steps rather than full autonomy at once—an approach reflected in regulatory pathways, clinical trials and commercial rollouts documented throughout 2024–2025.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.